Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.

Blood
Valerio W ValeriGenoveffa Franchini

Abstract

The identification of the genes necessary for human T-cell leukemia virus (HTLV-1) persistence in humans may provide targets for therapeutic approaches. We demonstrate that ablation of the HTLV-1 genes encoding p12, p30, or the HBZ protein, does not affect viral infectivity in rabbits and in this species, only the absence of HBZ is associated with a consistent reduction in virus levels. We observed reversion of the HTLV-1 mutants to the HTLV-1 wild-type genotype in none of the inoculated rabbits. In contrast, in macaques, the absence of HBZ was associated with reversion of the mutant virus to the wild-type genotype in 3 of the 4 animals within weeks from infection. Similarly, reversion to the wild type was observed in 2 of the 4 macaque inoculated with the p30 mutant. The 4 macaques exposed to the p12 knock remained seronegative, and only 2 animals were positive at a single time point for viral DNA in tissues. Interestingly, we found that the p12 and the p30 mutants were also severely impaired in their ability to replicate in human dendritic cells. These data suggest that infection of dendritic cells may be required for the establishment and maintenance of HTLV-1 infection in primate species.

References

Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·I J KoralnikG Franchini
Dec 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·B J PoieszR C Gallo
Jan 20, 2004·Nature Medicine·Christophe NicotGenoveffa Franchini
Apr 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Seung-Jae KimMichael D Lairmore
Jan 19, 2007·The Journal of Infectious Diseases·Vicki L Traina-DorgeMark A Beilke
Mar 16, 2007·The Journal of Biological Chemistry·Uma Sinha-DattaChristophe Nicot
Sep 19, 2007·International Journal of Hematology·Jean-Marie PeloponeseKuan-Teh Jeang

❮ Previous
Next ❯

Citations

Sep 23, 2003·Cellular Signalling·James F Curtin, Thomas G Cotter
Dec 6, 2012·Leukemia Research and Treatment·Francesca RendeVincenzo Ciminale
Oct 14, 2011·Viruses·Dustin EdwardsGenoveffa Franchini
Oct 14, 2011·Viruses·Michael D LairmorePatrick L Green
Oct 14, 2011·Viruses·Chloé Journo, Renaud Mahieux
Nov 28, 2015·Viruses·Pierre-Yves BarezLuc Willems
Jul 24, 2012·Current Opinion in Virology·Michael D LairmoreRajaneesh Anupam
Apr 23, 2013·Reviews in Medical Virology·Yorifumi Satou, Masao Matsuoka
Mar 17, 2016·Retrovirology·Guangyong MaMasao Matsuoka
Jul 22, 2014·Experimental Dermatology·Takatoshi Shimauchi, Vincent Piguet
Aug 15, 2014·Frontiers in Microbiology·Vincenzo CiminaleMaria G Romanelli
Nov 7, 2014·PLoS Pathogens·Cynthia A Pise-MasisonGenoveffa Franchini
Nov 12, 2015·Journal of Immunology Research·Carolina Rosadas, Marzia Puccioni-Sohler
Mar 24, 2016·Viruses·Christine Gross, Andrea K Thoma-Kress
Nov 18, 2017·Annual Review of Immunology·Charles R M Bangham
Jan 1, 2013·Virology : Research and Treatment·Amanda R PanfilPatrick L Green
Nov 27, 2015·Journal of Virology·Maria Fernanda de Castro-AmaranteGenoveffa Franchini
Jan 9, 2019·AIDS Research and Human Retroviruses·Priyanka NamdevRajaneesh Anupam
Nov 30, 2012·Uirusu·Yorifumi Satou
Dec 25, 2019·Retrovirology·Brenda RocamondeHélène Dutartre
Oct 1, 2020·PLoS Pathogens·Norbert DonhauserAndrea K Thoma-Kress
Dec 18, 2019·Retrovirology·Brice JégadoRenaud Mahieux
Dec 20, 2019·Retrovirology·Sarkis SarkisCynthia A Pise-Masison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.